Formula Balik
Volum lichid pleural (ml) = Distanta masurata ecografic (mm) x 20
pH lichid pleural < 7.2 = infectie
Formula Balik
Volum lichid pleural (ml) = Distanta masurata ecografic (mm) x 20
| Parametru | PAH Pulmonary Arterial Hypertension | PVH Pulmonary Venous Hypertension |
|---|---|---|
| RV | ↑ | ±↑ |
| LA | ↓ | ↑ |
| RA/LA Size ratio |
↑ | N ( LA > RA) |
| Sept interatrial | Impins spre stanga | Impins spre stanga |
| RVOT | Frecvent | Rar |
| E/A | < 1 | >1 |
| Lat e' | N | ↓ |
| Lat E/e' | < 8 | > 10 |
| Ao pressure | N / ↓ | N / ↑ |
| PCWP | ⋜ 15 mmHg | > 15 mmHg |
| PADP - PCWP | > 7 mmHg | < 5 mmHg |
Administrarea de rocuroniu
- doza de IOT calculata la IBW
0.6 mg/kg IBW (doza se scade cu 15 % pentru femei)
Monitorizare EMG
- TOF count sau PTC
- evitare administrare in ultimele 30 min ale procedurii daca este posibil
Reversie
Neostigmina 15-30 𝜇g/kg + Glicopirolat 1:5 imediat dupa neostigmina
Sugammadex 2 mg/kg
NU este nevoie de reversie
Sugammadex 4 mg/kg
Daca TOF ratio < 0.9 dupa reversie initiala se adminsitreaza Sugammadex
- dupa 3 minute daca reversia initiala a fost cu Sugammadex
- dupa 10 minute daca reversia initiala a fost cu Neostigmina
Antiagregante plachetare
Anticoagulante
Trombolitice/fibrinolitice
Mecanism:
- scavenging nitric oxide
- scade vasodilatatia
- catecholamine-sparing effect - scade necesarul de catelcolamine
Indicatii:
- intoxicatia cu cianuri
- hipotensiune refractara la administrarea de catecolamine
- efect antioxidant si mitocondrial
- socul vasoplegic post chirurgie cardiaca
Administrare:
- bolus 5 - 10 g in15 minute
Se poate repeta
Efecte secundare:
- colorare rosie a pielii, urinii si plasmei (temporar si fara alte efecte)
- hipertensiune (datorita vasoconstrictiei)
- interfera cu teste de laborator: HLG, creatinina, coagulare, lactat, bilirubina